PROKIDNEY CORP. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that PROKIDNEY CORP. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($16.47M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($16.55M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($16.73M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($17.91M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($12.51M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($9.49M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($10.98M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($9.12M) | Aug 9, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($9.67M) | May 10, 2024 |
| Q3 | 2022 | Sep 30, 2022 | ($29.93M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2022 | ($2.27M) | Aug 12, 2022 |
| Q2 | 2022 | Mar 31, 2022 | ($3.98M) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2022 | ($3.98M) | May 16, 2022 |
| Q3 | 2021 | Sep 30, 2021 | ($252.5K) | Nov 15, 2021 |
| Q3 | 2021 | Jun 30, 2021 | ($143) | Nov 15, 2021 |
| Q2 | 2022 | Jun 30, 2021 | ($143) | Aug 12, 2022 |
| Q2 | 2022 | Mar 31, 2021 | ($5.2K) | Aug 12, 2022 |
| Q3 | 2021 | Mar 31, 2021 | ($5.2K) | Nov 15, 2021 |
| Q1 | 2022 | Mar 31, 2021 | ($5.2K) | May 16, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($38.54M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($39.71M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($41.39M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($48.97M) | Nov 10, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($43.06M) | Aug 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($40.08M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($46.62M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($39.82M) | Aug 9, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($40.88M) | May 10, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($35.57M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($20.74M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($66.46M) | May 11, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($17.08M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($143) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($5.2K) | May 16, 2022 |